High-Performance Liquid Chromatography Assay for Moxifloxacin in Brain Tissue and Plasma: Validation in a Pharmacokinetic Study in a Murine Model of Cerebral Listeriosis
Moxifloxacin is a broad-spectrum antibacterial 8-methoxy-fluoroquinolone. In order to evaluate the pharmacokinetic properties of moxifloxacin in mouse plasma and brain tissue, we developed a high-performance liquid chromatography (HPLC) method. This study was based on single-drug delivery, intraveno...
Saved in:
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | Journal of Analytical Methods in Chemistry |
Online Access: | http://dx.doi.org/10.1155/2012/436349 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832566579928236032 |
---|---|
author | Renaud Respaud Solene Grayo Eric Singlas Sophie Dubouch Alban Le Monnier Marie-Catherine Lott |
author_facet | Renaud Respaud Solene Grayo Eric Singlas Sophie Dubouch Alban Le Monnier Marie-Catherine Lott |
author_sort | Renaud Respaud |
collection | DOAJ |
description | Moxifloxacin is a broad-spectrum antibacterial 8-methoxy-fluoroquinolone. In order to evaluate the pharmacokinetic properties of moxifloxacin in mouse plasma and brain tissue, we developed a high-performance liquid chromatography (HPLC) method. This study was based on single-drug delivery, intravenously dosed in a central listeriosis murine model. The method employed a reversed-phase Lichrospher RP-18 with a precolumn (250×4.6 mm) and a mobile phase composed of a mixture of acetonitrile, methanol, and citric buffer (pH=3.5) with sodium dodecyl sulfate and tetrabutylammonium bromide. Fluorescence detection was performed at an excitation wavelength of 290 nm and an emission wavelength of 550 nm. The relative standard deviation of intra- and inter-day assays was <10%. This validated method led to a short retention time (8.0 min) for moxifloxacin. The standard curves were linear from 5–250 μg/L in plasma and from 0.1–2.5 μg/g of brain tissue. The limits of quantification were 5 μg/L in plasma and 0.1 μg/g in brain tissue. The method enabled the detection of systemic antimicrobial in plasma and in CNS in Listeria-infected mice. Injected moxifloxacin passed through the encephalic barrier within a 30 to 60 min after injection time frame. Moxifloxacin pharmacokinetics are modeled in an infected model compared to control mice. |
format | Article |
id | doaj-art-e427d7d8a7504c66be48ca5245bf4f3f |
institution | Kabale University |
issn | 2090-8865 2090-8873 |
language | English |
publishDate | 2012-01-01 |
publisher | Wiley |
record_format | Article |
series | Journal of Analytical Methods in Chemistry |
spelling | doaj-art-e427d7d8a7504c66be48ca5245bf4f3f2025-02-03T01:03:48ZengWileyJournal of Analytical Methods in Chemistry2090-88652090-88732012-01-01201210.1155/2012/436349436349High-Performance Liquid Chromatography Assay for Moxifloxacin in Brain Tissue and Plasma: Validation in a Pharmacokinetic Study in a Murine Model of Cerebral ListeriosisRenaud Respaud0Solene Grayo1Eric Singlas2Sophie Dubouch3Alban Le Monnier4Marie-Catherine Lott5Laboratoire de Suivi Thérapeutique et de Contrôle des Médicaments, Service de Pharmacie, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Necker-Enfants Malades, 75015 Paris, FranceLaboratoire de Listeria, Centre National de Référence des Listeria and World Health Organization Collaborating Centre for Foodborne Listeriosis, Institut Pasteur, 75015 Paris, FranceLaboratoire de Suivi Thérapeutique et de Contrôle des Médicaments, Service de Pharmacie, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Necker-Enfants Malades, 75015 Paris, FranceLaboratoire de Suivi Thérapeutique et de Contrôle des Médicaments, Service de Pharmacie, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Necker-Enfants Malades, 75015 Paris, FranceLaboratoire de Listeria, Centre National de Référence des Listeria and World Health Organization Collaborating Centre for Foodborne Listeriosis, Institut Pasteur, 75015 Paris, FranceLaboratoire de Suivi Thérapeutique et de Contrôle des Médicaments, Service de Pharmacie, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Necker-Enfants Malades, 75015 Paris, FranceMoxifloxacin is a broad-spectrum antibacterial 8-methoxy-fluoroquinolone. In order to evaluate the pharmacokinetic properties of moxifloxacin in mouse plasma and brain tissue, we developed a high-performance liquid chromatography (HPLC) method. This study was based on single-drug delivery, intravenously dosed in a central listeriosis murine model. The method employed a reversed-phase Lichrospher RP-18 with a precolumn (250×4.6 mm) and a mobile phase composed of a mixture of acetonitrile, methanol, and citric buffer (pH=3.5) with sodium dodecyl sulfate and tetrabutylammonium bromide. Fluorescence detection was performed at an excitation wavelength of 290 nm and an emission wavelength of 550 nm. The relative standard deviation of intra- and inter-day assays was <10%. This validated method led to a short retention time (8.0 min) for moxifloxacin. The standard curves were linear from 5–250 μg/L in plasma and from 0.1–2.5 μg/g of brain tissue. The limits of quantification were 5 μg/L in plasma and 0.1 μg/g in brain tissue. The method enabled the detection of systemic antimicrobial in plasma and in CNS in Listeria-infected mice. Injected moxifloxacin passed through the encephalic barrier within a 30 to 60 min after injection time frame. Moxifloxacin pharmacokinetics are modeled in an infected model compared to control mice.http://dx.doi.org/10.1155/2012/436349 |
spellingShingle | Renaud Respaud Solene Grayo Eric Singlas Sophie Dubouch Alban Le Monnier Marie-Catherine Lott High-Performance Liquid Chromatography Assay for Moxifloxacin in Brain Tissue and Plasma: Validation in a Pharmacokinetic Study in a Murine Model of Cerebral Listeriosis Journal of Analytical Methods in Chemistry |
title | High-Performance Liquid Chromatography Assay for Moxifloxacin in Brain Tissue and Plasma: Validation in a Pharmacokinetic Study in a Murine Model of Cerebral Listeriosis |
title_full | High-Performance Liquid Chromatography Assay for Moxifloxacin in Brain Tissue and Plasma: Validation in a Pharmacokinetic Study in a Murine Model of Cerebral Listeriosis |
title_fullStr | High-Performance Liquid Chromatography Assay for Moxifloxacin in Brain Tissue and Plasma: Validation in a Pharmacokinetic Study in a Murine Model of Cerebral Listeriosis |
title_full_unstemmed | High-Performance Liquid Chromatography Assay for Moxifloxacin in Brain Tissue and Plasma: Validation in a Pharmacokinetic Study in a Murine Model of Cerebral Listeriosis |
title_short | High-Performance Liquid Chromatography Assay for Moxifloxacin in Brain Tissue and Plasma: Validation in a Pharmacokinetic Study in a Murine Model of Cerebral Listeriosis |
title_sort | high performance liquid chromatography assay for moxifloxacin in brain tissue and plasma validation in a pharmacokinetic study in a murine model of cerebral listeriosis |
url | http://dx.doi.org/10.1155/2012/436349 |
work_keys_str_mv | AT renaudrespaud highperformanceliquidchromatographyassayformoxifloxacininbraintissueandplasmavalidationinapharmacokineticstudyinamurinemodelofcerebrallisteriosis AT solenegrayo highperformanceliquidchromatographyassayformoxifloxacininbraintissueandplasmavalidationinapharmacokineticstudyinamurinemodelofcerebrallisteriosis AT ericsinglas highperformanceliquidchromatographyassayformoxifloxacininbraintissueandplasmavalidationinapharmacokineticstudyinamurinemodelofcerebrallisteriosis AT sophiedubouch highperformanceliquidchromatographyassayformoxifloxacininbraintissueandplasmavalidationinapharmacokineticstudyinamurinemodelofcerebrallisteriosis AT albanlemonnier highperformanceliquidchromatographyassayformoxifloxacininbraintissueandplasmavalidationinapharmacokineticstudyinamurinemodelofcerebrallisteriosis AT mariecatherinelott highperformanceliquidchromatographyassayformoxifloxacininbraintissueandplasmavalidationinapharmacokineticstudyinamurinemodelofcerebrallisteriosis |